Lv1
90 积分 2024-07-18 加入
Strategies for targeting cytokines in inflammatory bowel disease
14小时前
已完结
Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
19天前
已完结
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
3个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
3个月前
已完结
Chemerin Exacerbates Psoriasis by Stimulating Keratinocyte Proliferation and Cytokine Production
3个月前
已完结
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
3个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
4个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
5个月前
已完结
Neutrophils: from IBD to the gut microbiota
6个月前
已完结
Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study
6个月前
已完结
皖公网安备34019202002308
